Brightspring Health Services Inc. reported its financial results for the year ended December 31, 2024, highlighting a notable increase in revenues. The company recorded revenues of $10,072.2 million, marking a 31.0% increase from $7,691.0 million in the previous year. This growth was primarily driven by the expansion of the Pharmacy Solutions and Provider Services segments. Cost of goods for the year also rose significantly, amounting to $8,008.5 million compared to $5,840.7 million for the year ended December 31, 2023, reflecting a 37.1% increase. This rise was mainly attributed to higher costs within the Pharmacy Solutions segment. The company did not provide any specific outlook or guidance for the upcoming period in the available context.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.